Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein lateral stalk subunit P0 pseudogene 9 (RPLP0P9)
- Target
- RPLP0P9
- Molecular classification
- Pseudogene, Other
01
Overview
RPLP0P9 (ribosomal protein lateral stalk subunit P0 pseudogene 9) is a non-coding, processed pseudogene in the human genome, closely related in sequence to the functional ribosomal protein lateral stalk subunit P0 (RPLP0). Like other pseudogenes, RPLP0P9 arises from gene duplication or retrotransposition events and has lost the ability to produce a functional protein. Pseudogenes can sometimes be transcribed and play regulatory roles in gene expression by functioning as non-coding RNAs—serving, for example, as competitive endogenous RNAs that sequester microRNAs or as precursors for small interfering RNAs (siRNAs). However, there is currently no direct evidence of such functions or of disease association for RPLP0P9 specifically. It is not considered a canonical drug target, and no drugs or therapeutic strategies are aimed at this pseudogene[1][8][4].
- Other names
- RPLP0P9
02
Mechanism of action
None
03
Biological functions
Potential regulation of gene expression via non-coding RNA mechanisms (e.g., miRNA sponging or generation of siRNAs as commonly described for pseudogenes, although not directly shown for RPLP0P9)No evidence for direct protein-coding or canonical molecular function
04
Disease associations
OtherPseudogenes in general can be implicated in gene regulation, and their dysfunction can contribute to disease by acting as competitive endogenous RNAs or through effects on gene expression. There are no direct or robust disease associations reported for RPLP0P9 specifically.
Beyond the preview
Go deeper on Ribosomal protein lateral stalk subunit P0 pseudogene 9 (RPLP0P9).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein lateral stalk subunit P0 pseudogene 9 (RPLP0P9).